CMS transparency rules and AI could bring “Expedia-like” drug price comparisons for consumers, but payer compliance to transparency rules remains low.
News|Articles|February 1, 2011
Formulary Digital Edition February 2011
Contraceptive treatments: A review of current hormone options and newer agents for women; Focus on dabigatran; Agents in late-stage development for the treatment of cystic fibrosis.
Advertisement
Advertisement
Related to this article
A new Spherix Global Insights survey shows providers want administrative support for prior authorization while patients prioritize access and affordability
Pharmacy benefit managers are moving beyond formulary access to provide support programs for women's health. Here's how three PBMs — Judi Health, LucyRx and RxPreferred — are putting that strategy into practice.
Women face more gaps in healthcare than men, from missed screenings, undertreatment and biased coverage. PBMs are launching programs to address some of the gaps.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Texas A&M researchers discover promising therapy for fatty liver disease
2
Low birth volume, finances tied to hospital obstetric unit closures
3
Heather Burrell Ward, M.D., on personalizing TMS in schizophrenia
4
The hidden costs of routine radiology and how they can be addressed
5